These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 241249)

  • 1. The effect epsilon-aminocaproic acid hydrochloride on influenza infection in mice.
    Hrusková J; Jarý J
    Acta Virol; 1975 Sep; 19(5):435-36. PubMed ID: 241249
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of prophylactic administration of epsilon-amino caproic acid during influenza in mice.
    Puzis LE; Lozitsky VP; Polyak RYa
    Acta Virol; 1986 Jan; 30(1):58-62. PubMed ID: 2871734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 60amino-6-deoxy-D-glucose hydrochloride on influenza infection in mice.
    Hrusková J; Jarý J; Danes L; Jelínková A; Novák M
    Acta Virol; 1975 Jan; 19(1):47-51. PubMed ID: 235197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study of the prophylactic anti-influenza and interferon-inducing activity of epsilon-aminocaproic acid].
    Kremerman IB; Priĭmiagi LS; Lozitskiĭ VP; Tefanova VT
    Antibiot Khimioter; 1988 Jan; 33(1):63-7. PubMed ID: 2454085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic and therapeutic effects of murabutide in OF1 mice infected with influenza A/H3N2 (A/Texas/1/77) virus.
    Chomel JJ; Simon-Lavoine N; Thouvenot D; Valette M; Choay J; Chedid L; Aymard M
    J Biol Response Mod; 1988 Dec; 7(6):581-6. PubMed ID: 2851033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of epsilon-aminocaproic acid on the proteolysis system during experimental influenza in mice.
    Puzis LE; Lozitsky VP
    Acta Virol; 1988 Nov; 32(6):515-21. PubMed ID: 2906223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. II. A clinical study with the aid of intravenous phlebography.
    Becker J; Borgström S; Saltzman GF
    Acta Chir Scand; 1970; 136(3):167-71. PubMed ID: 4103355
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistance of mice to reinfection after E-aminocaproic acid treatment of primary influenza virus infection.
    Lozitsky VP; Puzis LE; Polyak RYa
    Acta Virol; 1988 Mar; 32(2):117-22. PubMed ID: 2899958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epsilon-aminocaproic acid as an anti-allergic agents in surgical practice].
    Zatikian LO
    Klin Med (Mosk); 1975 Nov; 53(11):103-6. PubMed ID: 1223500
    [No Abstract]   [Full Text] [Related]  

  • 10. [Administration of epsilon-aminocaproic acid].
    Hrodek O
    Cesk Pediatr; 1968 May; 23(5):465-7. PubMed ID: 5660458
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of epsilon-aminocaproic acid as an anti-allergic agent and its effect on blood coagulation system].
    Zatikian LO
    Zh Eksp Klin Med; 1973; 13(3):16-9. PubMed ID: 4791710
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influenza vaccination: reinforcement of its effectiveness by combination with an immunostimulant].
    German A; Fattal-German M; Quero AM; Bizzini B
    Bull Acad Natl Med; 1988 Mar; 172(3):467-74. PubMed ID: 3048551
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. A study in experimental animals and in clinical material.
    Becker J; Borgström S
    Acta Chir Scand; 1968; 134(5):343-9. PubMed ID: 5731268
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of delayed skin reaction by epsilon-aminocaproic acid.
    Miller JM
    Exp Med Surg; 1971; 29(1):132-4. PubMed ID: 5147594
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of 5-nitrofurfural acetals. 4. Antiviral effect of 5-nitro-2-furfural-diethyl acetal on the influenza virus A-PR8].
    Kewitsch A; Weuffen W; Becker R
    Arch Exp Veterinarmed; 1968; 22(1):143-9. PubMed ID: 5681879
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical aminocaproic acid in hemophiliac patients undergoing dental extraction.
    Casdorph DL
    DICP; 1990 Feb; 24(2):160-1. PubMed ID: 2309511
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of epsilon-aminocaproic acid to influence histamine relase by polymyxin B.
    Zachariae H
    Acta Derm Venereol; 1968; 48(4):322-4. PubMed ID: 4179042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.